New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 19, 2013
07:44 EDTMSTX, BLUEPiper Jaffray to host a conference
2nd Annual Sickle Cell Disease Therapeutics Conference is being held in New York on September 19.
News For MSTX;BLUE From The Last 14 Days
Check below for free stories on MSTX;BLUE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
07:26 EDTBLUE, MSTXPiper Jaffray to hold a conference
Subscribe for More Information
September 8, 2014
08:01 EDTMSTXMast Therapeutics announces positive results from Phase 2 study of AIR001
Mast Therapeutics reported top-line results from a Phase 2 study of AIR001 inhalation solution for the treatment of pulmonary arterial hypertension. Mast obtained the rights to the AIR001 program through its acquisition of privately-held Aires Pharmaceuticals earlier this year. In the primary efficacy analysis of the Phase 2 study, all doses showed improvement in median pulmonary vascular resistance. In the secondary efficacy analysis, all doses showed improvements in the median distances obtained in the 6-minute walk test, including clinically-meaningful improvements at the highest dose level. Additionally, AIR001 was well-tolerated, with no treatment related serious adverse events. In particular, methemoglobin levels remained normal, which distinguishes AIR001 from safety concerns associated with intravenously-administered nitrite.
September 4, 2014
17:57 EDTBLUEbluebird bio initiated with a Buy at SunTrust
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use